Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.46 |
| ▸ | FABP7 | O15540 | 1/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21895386 | 0.86 | HPGD (0.40) | SLC6A3HPGDL3MBTL1POLBALDH1A1 | |
| SCHEMBL21896023 | 0.86 | NPC1 (0.44) | HPGDL3MBTL1POLBALDH1A1NPC1 | |
| SCHEMBL21895380 | 0.86 | HPGD (0.58) | SLC6A3FABP7FABP5HPGDL3MBTL1 | |
| SCHEMBL21895387 | 0.85 | CYP3A4 (0.41) | HPGDALDH1A1MAPTMAPK1 | |
| SCHEMBL21895385 | 0.85 | ALDH1A1 (0.41) | SLC6A3HPGDL3MBTL1POLBALDH1A1 | |
| SCHEMBL21895425 | 0.84 | HPGD (0.41) | SLC6A3HPGDL3MBTL1POLBALDH1A1 | |
| SCHEMBL21895378 | 0.84 | FABP7 (0.46) | FABP7FABP5HPGDALDH1A1 | |
| SCHEMBL21895658 | 0.83 | HPGD (0.40) | SLC6A3HPGDL3MBTL1POLBALDH1A1 | |
| SCHEMBL21895654 | 0.83 | HPGD (0.40) | HPGDL3MBTL1POLBALDH1A1NPC1 | |
| SCHEMBL23912199 | 0.82 | ALDH1A1 (0.50) | SLC6A3HPGDPOLBALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200115400-A1 | METHOD FOR PRODUCING SILICON COMPOUND, AND SILICON COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200115400-A1 | METHOD FOR PRODUCING SILICON COMPOUND, AND SILICON COMPOUND | SI, SIK1, CA1 | SLC6A3 3883/4885FABP7 4297/4885FABP5 4263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.